ArticleNutrients2026
Multi-Omics Analysis Reveals the Potential Role of
Fan Yang, Siyi Xie, Wenjing Yang, Chuanhong Zhu, Yurong Chen, Haozhuo Yang, Hongxia Yuan, Qingshan Li
Abstract read
In one paragraphArticle in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Fan YangMedicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, School of Pharmacy, Shanxi Medical University, Jinzhong 030600, China.ORCID 0009-0000-8978-7871 Siyi XieMedicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, School of Pharmacy, Shanxi Medical University, Jinzhong 030600, China.
Wenjing YangMedicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, School of Pharmacy, Shanxi Medical University, Jinzhong 030600, China.ORCID 0009-0009-4333-6456 Chuanhong ZhuMedicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, School of Pharmacy, Shanxi Medical University, Jinzhong 030600, China.
Yurong ChenMedicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, School of Pharmacy, Shanxi Medical University, Jinzhong 030600, China.
Haozhuo YangMedicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, School of Pharmacy, Shanxi Medical University, Jinzhong 030600, China.
Hongxia YuanShanxi Key Laboratory of Innovative Drug for the Treatment of Serious Diseases Basing on the Chronic Inflammation, College of Traditional Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China.
Qingshan LiMedicinal Basic Research Innovation Center of Chronic Kidney Disease, Ministry of Education, School of Pharmacy, Shanxi Medical University, Jinzhong 030600, China.ORCID 0009-0006-0036-640X Funding
Shanxi Medical University No. CKD/SXMU-2025-07Shanxi Science and Technology Department No. 202303021221129
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Gastrointestinal MicrobiomeJaundicePlant ExtractsAnimalsBilirubinDisease Models, AnimalLimosilactobacillus reuteriLiverMaleMiceMultiomicsPhenylhydrazinesBilirubinphenylhydrazinePhenylhydrazinesPlant Extractsgut-liver axisgut microbiotahemolytic jaundiceInonotus obliquus
Identifiers
PMID42884675
PMCPMC13667189
What OpenQuestion holds
Textmetadata
Read underepoch 390